ID
45727
Descripción
Principal Investigator: Xin Wei Wang, PhD, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Carcinoma, Hepatocellular,Cholangiocarcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001199 Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We performed targeted sequencing of Thai ICC and HCC among the Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC) cohort using the OncoVar platform.
Link
Palabras clave
Versiones (1)
- 25/5/23 25/5/23 - Chiara Middel
Titular de derechos de autor
Xin Wei Wang, PhD, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Subido en
25 de mayo de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs001199 TIGER-LC OncoVar Sequencing
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for liver cancers.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This subject phenotype table contains subject ID, sex, and age at diagnosis.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, histological type [normal, cholangiocarcinoma (CCA), or hepatocellular carcinoma (HCC)], and name of the center which conducted sequencing.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for liver cancers.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This subject phenotype table contains subject ID, sex, and age at diagnosis.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, histological type [normal, cholangiocarcinoma (CCA), or hepatocellular carcinoma (HCC)], and name of the center which conducted sequencing.
C0680251 (UMLS CUI [1,2])
C1551358 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,3])
C0030705 (UMLS CUI [1,4])
C0521093 (UMLS CUI [1,5])
C0919386 (UMLS CUI [1,6])
C0205225 (UMLS CUI [1,7])
C2239176 (UMLS CUI [1,8])
C0242800 (UMLS CUI [1,9])
C0001779 (UMLS CUI [1,10])
C0680251 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])